Navigation Links
Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
Date:10/27/2011

STEVENSVILLE, Md., Oct. 27, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today receiving FDA clearance for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox).  The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Heliox is used in a variety of respiratory applications such as upper airway obstruction, asthma, croup and COPD. "We are pleased to receive clearance for the new Precision Flow® Heliox system, the first high flow device developed specifically for use with this specialty gas," said Bill Niland, Chief Business Development Officer at Vapotherm.  "The device provides clinicians with a rapid, easy to use approach to administer heliox via nasal cannula, without the risks of more invasive methods like mechanical ventilation and pressure based therapies."

Vapotherm's High Flow Specialty Gas Program was created to expand High Flow Therapy (HFT®) beyond air and oxygen to other medical and specialty gases.  The Company's flagship platform device, the Precision Flow, was developed with a modular design concept to allow for several specialty applications in neonatal, pediatric and adult patient populations. In all applications, the device optimizes the delivery of gases via precise blending, flow control, humidification and temperature management.  As with all Vapotherm HFT® products, the overall goal is non-invasive respiratory support via simple nasal cannula in a device that is easy for clinicians to operate but comprehensive in terms of safety and performance features.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

Contact: Kevin Thibodeau, Executive Vice President of Sales and Marketing

410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
2. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
3. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
4. Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
6. CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies
7. Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing
8. Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimers Disease and Other Proteinopathies
9. Perrigo Company Announces Quarterly Dividend
10. MiMedx Group Announces Third Quarter 2011 Results
11. Anthera Announces Last Patient Enrolled in PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)...  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) ... th Annual Healthcare Conference on Monday, March 6, ... MA. A live webcast of Infinity,s presentation ... website at www.infi.com , and will be available ... Infinity,Infinity is an innovative biopharmaceutical company dedicated to advancing ...
(Date:2/27/2017)... A recent research report published by Grand View Research, ... to reach a value of $55.8 billion by 2025. Earlier in ... have legalized marijuana for medical uses. In 2016, states such as ... North Dakota , Ohio and ... in medical applications such as chemotherapies and pain management. The growing ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... February 28, 2017 , ... TruClinic Inc. announced ... company based in New York. , “Ensuring an intuitive, user-friendly patient experience is ... Those two fundamental reasons are the reasons this acquisition is an obvious one,” ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... has challenges as they transition from military to civilian life. Body image dissatisfaction ... million who experience poorer health and greater occurrence of chronic mental health conditions ...
(Date:2/27/2017)... ... 27, 2017 , ... Bo Chen, PhD is the recipient of the 2017 ... during the Plenary Session at ASLMS 2017, the Annual Conference of the American Society ... April 5-9, 2017. , During the Plenary Session on April 7, Dr. Chen ...
(Date:2/27/2017)... ... 2017 , ... Hotze Health & Wellness Center (HHWC), a ... New Guest Director. , Brandl is a dynamic and influential executive leader ... his professional career at Omnium Worldwide, now known as West Corporation, and handled ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Shamanic Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation ... and body, these individual customized retreats offer the winter-weary soul an excellent opportunity ...
Breaking Medicine News(10 mins):